SCHEDULE 13D/A
Beneficial Ownership Report
X4 Pharmaceuticals, Inc Filed Acc 0001072613-25-000747
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Growth Equity Opportunities 18 VGE, LLC | 5,057,610 | 6.2% |
| NEA 18 Venture Growth Equity, L.P. | 5,057,610 | 6.2% |
| NEA Partners 18 VGE, L.P. | 5,057,610 | 6.2% |
| NEA 18 VGE GP, LLC | 5,057,610 | 6.2% |
| Ali Behbahani | 5,057,610 | 6.2% |
| Carmen Chang | 5,057,610 | 6.2% |
| Anthony A. Florence, Jr. | 5,057,610 | 6.2% |
| Mohamad H. Makhzoumi | 5,057,610 | 6.2% |
| Edward T. Mathers | 5,057,610 | 6.2% |
| Scott D. Sandell | 5,057,610 | 6.2% |
| Paul Walker | 5,057,610 | 6.2% |
| Rick Yang | 5,057,610 | 6.2% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13D_X01/primary_doc.xml…